Skip to main content

Table 3 Predictive values of GHD predictors.

From: Selecting short-statured children needing growth hormone testing: Derivation and validation of a clinical decision rule

    

Clinical decision rule***

 

Growth rate < -1 SD

BMI ≥ 0 z-score

IGF-I < -2 SD

Construction†

Validation‡

GHD

All

Certain

All

Certain

All

Certain

All

Certain

 

Sensitivity

77 [60–90]

100 [48–100]

47 [31–63]

60 [15–95]

78 [64–91]

100 [48–100]

63 [47–79]

100 [48–100]

92 [76–100]

Specificity

50 [41–58]

Idem

76 [69–83]

Idem

37 [29–46]

Idem

68 [60–76]

Idem

70 [53–88]

PPV*

30 [20–39]

7 [2–16]

35 [22–48]

9 [2–24]

25 [17–34]

6 [2–13]

35 [23–47]

11 [2–20]

Not applicable

NPV**

89 [79–95]

100 [94–100]

84 [77–91]

98 [95–100]

86 [77–95]

100 [93–100]

87 [80–94]

100 [92–100]

Not applicable

  1. Values are expressed in % [95% CI]
  2. * Positive predictive value
  3. ** Negative predictive value
  4. *** To test patients with growth rate < -I SD and IGF-I < -2 SD
  5. † Construction population
  6. ‡ Validation population